Honz Pharmaceutical Co (SZSE:300086) 3-Year EBITDA Growth Rate : 8.90% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Honz Pharmaceutical Co 3-Year EBITDA Growth Rate?

Honz Pharmaceutical Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥-0.10.

During the past 3 years, the average EBITDA Per Share Growth Rate was 8.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Honz Pharmaceutical Co was 61.40% per year. The lowest was -38.60% per year. And the median was -5.00% per year.

Competitive Comparison of Honz Pharmaceutical Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Honz Pharmaceutical Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Honz Pharmaceutical Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Honz Pharmaceutical Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Honz Pharmaceutical Co's 3-Year EBITDA Growth Rate falls into.

Honz Pharmaceutical Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Honz Pharmaceutical Co (SZSE:300086) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Honz Pharmaceutical Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Honz Pharmaceutical Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Honz Pharmaceutical Co (SZSE:300086) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Honz Pharmaceutical Co Ltd (SZSE:300086) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

No. 69 Xianlie Zhonglu, 2601 26/F Dongshan Plaza, GuangDong,Province, Guangzhou, CHN, 510095

Website

http://www.honz.com.cn

Honz Pharmaceutical Co Ltd is engaged in providing medicines for children. The company's practice in this sector mainly involves the research and development, manufacturing and sales of pediatric medicines. It has automated and intelligent manufacturing bases in Hainan, Beijing, Hebei, Liaoning, and Guangdong.

Executives

Wang Chun Ying	Supervisors
Rui Shou Hong	Director
Hong Jiang You	Directors, executives
Hong Zhi Hui	Director
He Zi Qun	Supervisors
Hong Li Ping	Directors, executives
Hong Jiang Tao	Director
Liu Hui Liang	Executives
Hu Fei Hong	Director
Li Ping	Independent director
Fu Lin Jun	Director

Honz Pharmaceutical Co (SZSE:300086) Headlines

No Headlines